Lutz Hegemann, M.D., Ph.D., President, Global Health & Sustainability
Lutz Hegemann, M.D., Ph.D., President, Global Health & Sustainability

Lutz Hegemann, M.D., Ph.D.

President, Global Health & Sustainability

Lutz Hegemann, M.D., Ph.D.

President, Global Health & Sustainability

Nationality: German | Year of birth: 1966

Lutz Hegemann leads the Novartis Global Health unit and is responsible for integrating environmental, social and governance (ESG) matters into the core of the company’s business, with a special emphasis on innovation and access. The Global Health unit focuses on transforming health in low- and middle-income countries with programs targeting malaria, neglected tropical diseases, and non-communicable diseases such as sickle cell disease. It also represents the company’s business in sub-Saharan Africa.

We are pursuing a coordinated approach to maximize our contribution to society and ensure as many patients as possible have access to our treatments, helping to build a strong foundation for the next phase of our global health and ESG journey.

Before taking on his present role, Lutz was Group Head of Corporate Affairs and Global Health. He has held roles of increasing responsibility since joining Novartis in 2005 in the Consumer Health Division. He began his career as a public health physician and scientist.

Lutz is a Fellow of the Royal Society for Tropical Medicine & Hygiene and serves on the boards of the Novartis Foundation, the Swiss Alliance against Neglected Tropical Diseases, the Tanzania Training Centre of International Health, PATH, and the Swiss Tropical and Public Health Institute.

Lutz Hegemann, M.D., Ph.D., President, Global Health & Sustainability

Nationality: German | Year of birth: 1966

Lutz Hegemann leads the Novartis Global Health unit and is responsible for integrating environmental, social and governance (ESG) matters into the core of the company’s business, with a special emphasis on innovation and access. The Global Health unit focuses on transforming health in low- and middle-income countries with programs targeting malaria, neglected tropical diseases, and non-communicable diseases such as sickle cell disease. It also represents the company’s business in sub-Saharan Africa.

We are pursuing a coordinated approach to maximize our contribution to society and ensure as many patients as possible have access to our treatments, helping to build a strong foundation for the next phase of our global health and ESG journey.

Before taking on his present role, Lutz was Group Head of Corporate Affairs and Global Health. He has held roles of increasing responsibility since joining Novartis in 2005 in the Consumer Health Division. He began his career as a public health physician and scientist.

Lutz is a Fellow of the Royal Society for Tropical Medicine & Hygiene and serves on the boards of the Novartis Foundation, the Swiss Alliance against Neglected Tropical Diseases, the Tanzania Training Centre of International Health, PATH, and the Swiss Tropical and Public Health Institute.

Information is accurate as of August 1, 2022